Filing Details

Accession Number:
0001209191-13-055725
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-06 16:24:17
Reporting Period:
2013-12-04
Filing Date:
2013-12-06
Accepted Time:
2013-12-06 16:24:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1168197 Liposcience Inc LPDX In Vitro & In Vivo Diagnostic Substances (2835) 561879288
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1187406 J Daniel Levangie C/O Liposcience, Inc.
2500 Sumner Boulevard
Raleigh NC 27616
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-12-04 10,000 $4.17 10,000 No 4 P Indirect Held by Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Held by Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,122 Direct
Footnotes
  1. Price reflected is the weighted-average purchase price for shares purchased. The range of purchase prices for the transactions reported was $4.03 to $4.24 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
  2. Shares are held by the Daniel J. Levangie Family Trust (the "Levangie Trust"). The reporting person is trustee of the Levangie Trust.